US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 3.490
- -0.040-1.13%
Close Nov 14 16:00 ET
- 3.490
- 0.0000.00%
Post 20:01 ET
37.64MMarket Cap-1960P/E (TTM)
3.599High3.450Low76.99KVolume3.510Open3.530Pre Close269.87KTurnover0.97%Turnover RatioLossP/E (Static)10.78MShares11.99052wk High1.42P/B27.79MFloat Cap3.04052wk Low--Dividend TTM7.96MShs Float24.840Historical High--Div YieldTTM4.22%Amplitude2.380Historical Low3.505Avg Price1Lot Size
About Lantern Pharma Company
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.
Company Profile
SymbolLTRN
Company NameLantern Pharma
Listing DateJun 11, 2020
Issue Price15.00
Founded2013
CEOMr. Panna L. Sharma
MarketNASDAQ
Employees21
Fiscal Year Ends12-31
Address1920 McKinney Avenue,7th floor
CityDallas
ProvinceTexas
CountryUnited States of America
Zip Code75201
Phone1-972-277-1136
Websitehttp://www.lanternpharma.com
Company Executives
- Name
- Position
- Salary
- Panna L. Sharma
- Chief Executive Officer, President and Director
- 684.39K
- Dr. Kishor G. Bhatia, PhD
- Chief Scientific Officer
- 283.24K
- David R. Margrave
- Principal Accounting Officer, Chief Financial Officer and Secretary
- 442.68K
- Donald Jeffrey Keyser
- Chairman of the Board
- 56.00K
- David S. Silberstein
- Director
- 46.00K
- Dr. Vijay Chandru
- Independent Director
- 46.00K
- Dr. Maria Maccecchini, PhD
- Independent Director
- 51.00K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data